Loading insider details...
Beta
Latest Form 4 (Apr 22, 2026): Grant/Award of 24,367 IRD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 22, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 24,367 | n/a |
| Feb 17, 2026 | TuHURA Biosciences, Inc./NV (HURA) | Grant/Award | 156,240 | n/a |
| Jan 5, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 31,188 | n/a |
| May 2, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 79,504 | n/a |
| Jan 6, 2025 | TuHURA Biosciences, Inc./NV (HURA) | Grant/Award | 59,590 | n/a |
| Jan 6, 2025 | Opus Genetics, Inc. (IRD) | Grant/Award | 50,222 | n/a |
| Oct 23, 2024 | Kintara Therapeutics, Inc. (KTRA) | Grant/Award | 13,553 | n/a |
| Jun 13, 2024 | Ocuphire Pharma, Inc. (OCUP) | Grant/Award | 41,143 | n/a |
| Jan 3, 2024 | Ocuphire Pharma, Inc. (OCUP) | Grant/Award | 22,090 | n/a |
| Jun 8, 2023 | Ocuphire Pharma, Inc. (OCUP) | Grant/Award | 10,976 | n/a |